CardioSCOPE

Revolutionizing CV Health in Europe 🌐 | ML/AI and Multi-Omics for ACS & MACE 💙 | MSCA-SE CardioSCOPE Project: Empowering scientists for the "omics" era! 🔬✨

[EHJ Editor-in-Chief @ehj_ed]

Elevated C-reactive protein in the general population is linked to higher cardiovascular risk, reinforcing the role of inflammation in heart disease. Read more in #EHJ.
https://t.co/IOEg0NfBz4
#CRP #inflammation #cardiotwitter @ESC_Journals @escardio

[EHJ Editor-in-Chief @ehj_ed]

Plaque erosion now drives one-third of all acute coronary syndrome cases. Thanks to OCT, we can see the biology in real time and rethink treatment beyond plaque rupture. The era of personalized acute coronary sybdrome care is here. Read more in #EHJ.
https://t.co/GoPwouSu71
#Erosion #Plaque #ACS #OCT #cardiotwitter @ESC_Journals @escardio

[EHJ Editor-in-Chief @ehj_ed]

Frailty and long-term outcomes in younger patients with acute myocardial infarction. Read more in the @EHJ at https://t.co/zgO3vNa1HO #AcuteMyocardialInfarction #Frailty #LongTermOutcomes @ESCardio @ESC_journals

[EHJ Editor-in-Chief @ehj_ed]

Atherosclerosis is a chronic inflammatory disease of the arterial wall. New study reveals that enhanced antigen presentation by macrophages activates local T-cell inflammatory response.
https://t.co/03tdHEdoTK
#atherosclerosis #inflammation #cardiotwitter, @ESC_Journals, @escardio

[EAS Congress @EASCongress]

One month left!
Share your research with the global cardiovascular community at #EASCongress2026, 24–27 May 2026 in Athens.
Be part of the dialogue shaping the future of atherosclerosis research.
📅 Deadline: 3 Dec 2025
🔗 https://t.co/U8P3Mk6RTo #Atherosclerosis

[European Society of Cardiology Journals @ESC_Journals]

Cardiovascular biomarkers for risk stratification in primary prevention. Read this State-of-the-Art review in #EHJ 👉 https://t.co/aOKqJc8ilT
@RoccoMontone @ehj_ed

[European Society of Cardiology @escardio]

1 in 3 cancer patients may experience serious cardiovascular side effects from treatment.

For the first time, experts from cardiology, oncology, haematology, radiology, nursing and more are meeting under one roof at #ESCardioOnco2025

United by a shared mission to improve care for these patients, this conference, in Florence, Italy, is groundbreaking.

It’s not just about sharing science. It’s active collaboration between specialties, to avoid a cardio-oncology epidemic. Thank you to all contributors and attendees for being part of this event.

[EHJ Editor-in-Chief @ehj_ed]

AI-driven body tissue segmentation to analyze CT scans, revealing key correlations and outcome associations. A step toward personalized risk stratification. Read more in #EHJ.
https://t.co/vUdiSjdRac
#ACC2025 #cardiotwitter @ESC_Journals @escardio

[EHJ Editor-in-Chief @ehj_ed]

The role of low-density lipoprotein cholesterol, C-reactive protein, and lipoprotein(a) in cardiovascular risk assessment for early intervention. Read more about the EPIC-Norfolk study in #EHJ.
https://t.co/wUsPMmfy3V
#atherosclerosis #cardiotwitter @ESC_Journals @escardio

[EHJ Editor-in-Chief @ehj_ed]

Lipid lowering therapy and sustained weight management: a winning combination in patients with heterozygous familial hypercholesterolaemia!

https://t.co/468TzNqj7U

#cholesterol #lipid #lowering #obesity #EHJ #cardiotwitter @ESC_journals @escardio

[EHJ Editor-in-Chief @ehj_ed]

Heart failure risk stratification using artificial intelligence applied to electrocardiogram images: a multinational study. Read more in #EHJ https://t.co/Le5S3frmp9
#HeartFailure #ArtificialIntelligence #ECG #MachineLearning @ESCardio @ESC_Journals

[Heart_BMJ @Heart_BMJ]

Functional assessment of coronary artery disease in patients with severe aortic stenosis: a review https://t.co/hZmQqi54fW

[EAS Congress @EASCongress]

Only two weeks left to register at regular rates for #EASCongress2025. Don’t wait any longer - secure your spot in Glasgow! 👉 https://t.co/04vFQWQrTA

#CardiovascularHealth #Cardiovascular #AtherosclerosisResearch #HeartHealthExperts

[AtheroNET COST Action @AtheroNET]

Our heart disease infographics are now in multiple European languages! 🌍🫀 They cover risk factors & the use of AI + multiomics in heart disease research. Check them out & share! 🔗 https://t.co/VPKcT2P8dL
#HeartHealth #AI #Multiomics #AtheroNET

[European Society of Cardiology Journals @ESC_Journals]

#ANOCA versus obstructive CAD – a comparison between pre- and post-angiography clinical characteristics, management and outcomes. More in https://t.co/whJnIDrbcW

#EHJQCCO #CVD #@cpgale3 @diogoasantosfer @m_piepoli

[EHJ Editor-in-Chief @ehj_ed]

The year in cardiovascular medicine 2024: the top 10 papers in thrombosis and antithrombotic treatment. Read more in #EHJ!
@escardio @ESC_Journals #thrombosis

https://t.co/SvD1JqjhLc

[EHJ Editor-in-Chief @ehj_ed]

Handle with care, proceed with caution: do frail patients presenting with acute coronary syndrome benefit from revascularization? Read more in #EHJ:
https://t.co/0c6iYpdCLO

@escardio @ESC_Journals

[European Alliance for Cardiovascular Health (EACH) @EUCVHAlliance]

🎉 Commissioner for Health and Animal Welfare Mr Olivér Várhelyi announces that the European Commission will develop a new European Cardiovascular Health Plan ⤵️ 📽️

The success and impact of a European CVH Plan will depend not only on what is achieved in the next few years but on how it is achieved so that no one and no country is left behind. EACH calls on addressing societal barriers, underserved populations, discrimination on all grounds, and fundamental inequities that permeate health systems across Europe. At EACH, we know that the time to act is now.

Read about the EACH plan and our asks here: https://t.co/SUKwsRYHa1 #CVHealthForAll #EUCVHPlan

[EHJ Editor-in-Chief @ehj_ed]

Handle with care, proceed with caution: do frail patients presenting with acute coronary syndrome benefit from revascularization? Read more in EHJ.
@ESCardio @ESC_Journals #frailty #ACS #revascularization